Insights into the Epidermal Growth Factor Receptor-Non Small Cell Lung Cancer Market (2017 to 2030) - Featuring AstraZeneca, Pfizer & Takeda Among Others - ResearchAndMarkets.com

Source :: Business Wire. May 14, 2020
Publication Year :: 2020
Abstract: DUBLIN -- The 'Epidermal Growth Factor Receptor-Non Small Cell Lung Cancer (EGFR-NSCLC)-Market Insights, Epidemiology and Market Forecast - 2030' drug pipelines has been added to ResearchAndMarkets.com's offering. This report delivers [...]

Subjects :: Novartis Pharma AG -- Forecasts and trends
Osimertinib -- Forecasts and trends -- Reports
Small cell lung cancer -- Forecasts and trends -- Reports
Epidermal growth factors -- Reports -- Forecasts and trends
Epidemiology -- Reports -- Forecasts and trends
Pharmaceutical industry -- Forecasts and trends
Non-small cell lung cancer -- Reports -- Forecasts and trends
Dacomitinib
Lung cancer
Profits
Market trend/market analysis
Business
Business, international

Tools